Skip to main content
TipRanks
Go Ultimate75% OFF
Triomics logo

Triomics: Valuation, Funding & Investors

Triomics is an oncology AI company that helps cancer centers operationalize complex clinical information to improve clinical decision-making and care delivery. The company develops a platform that integrates and analyzes clinical, genomic, and operational data to support clinicians, clinical trials, and life-sciences partnerships.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$22M
Total Funding Rounds
1
Latest Funding Amount
$22M
Latest Funding Round
Series B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
May 28, 2026Series B$22.00M―

Investors

Investor NameFunding Round
Battery VenturesSeries B
Nexus Venture PartnersSeries B
LightspeedSeries B
Y CombinatorSeries B
Oncology VenturesSeries B
Precision Health InformaticsSeries B

Similar Companies

A snapshot of private companies similar to Triomics, helping you discover and navigate related company profiles.

Related News and Analysis